Search

everythinglearnresearchcommunity

for

Search:↓

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Using more low-cost and generic drugs could save Medicare Part D a lot of money.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

3βHSD2 is not useful for diagnosing PCOS.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Testosterone affects blood vessel relaxation in hypertensive rats.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Poor sleep, physical health, depression, and anxiety can worsen urinary problems in men.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Clinicians need to better understand and treat Post-finasteride syndrome.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Lower SHBG levels may increase the risk of PCOS.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.